SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-009961
Filing Date
2021-03-04
Accepted
2021-03-04 19:20:26
Documents
2
Period of Report
2021-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1603
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4612
  Complete submission text file 0000899243-21-009961.txt   7527
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Issuer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DYNE THERAPEUTICS, INC. 830 WINTER STREET MA 02451
Business Address
Farwell Wildon (Reporting) CIK: 0001847941 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39509 | Film No.: 21715984